Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | PIK3CA |
Variant | V955G |
Impact List | missense |
Protein Effect | gain of function - predicted |
Gene Variant Descriptions | PIK3CA V955G lies within the PI3K/PI4K domain of the Pik3ca protein (UniProt.org). V955G results in activation of Pik3ca signaling as indicated by increased phosphorylation of Akt and Mapk3/Mapk1 (Erk1/2), and confers resistance to Erbitux (cetuximab) in culture (PMID: 28424201), and therefore, is predicted to lead to a gain of Pik3ca protein function. |
Associated Drug Resistance | Y |
Category Variants Paths |
PIK3CA mutant PIK3CA act mut PIK3CA V955G PIK3CA mutant PIK3CA exon20 PIK3CA V955G |
Transcript | NM_006218.4 |
gDNA | chr3:g.179230304T>G |
cDNA | c.2864T>G |
Protein | p.V955G |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_006713658 | chr3:g.179230304T>G | c.2864T>G | p.V955G | RefSeq | GRCh38/hg38 |
NM_006218.3 | chr3:g.179230304T>G | c.2864T>G | p.V955G | RefSeq | GRCh38/hg38 |
XM_011512894.2 | chr3:g.179230304T>G | c.2864T>G | p.V955G | RefSeq | GRCh38/hg38 |
NM_006218.4 | chr3:g.179230304T>G | c.2864T>G | p.V955G | RefSeq | GRCh38/hg38 |
XM_006713658.4 | chr3:g.179230304T>G | c.2864T>G | p.V955G | RefSeq | GRCh38/hg38 |
NM_006218 | chr3:g.179230304T>G | c.2864T>G | p.V955G | RefSeq | GRCh38/hg38 |
XM_011512894 | chr3:g.179230304T>G | c.2864T>G | p.V955G | RefSeq | GRCh38/hg38 |
XM_006713658.5 | chr3:g.179230304T>G | c.2864T>G | p.V955G | RefSeq | GRCh38/hg38 |
Molecular Profile | Protein Effect | Treatment Approaches |
---|---|---|
PIK3CA V955G | gain of function - predicted | Akt Inhibitor (Pan) Akt1 Inhibitor Akt2 Inhibitor mTOR Inhibitor mTORC1 Inhibitor mTORC2 Inhibitor PI3K Inhibitor (Pan) PIK3CA inhibitor |